Selected article for: "clinical surveillance and respiratory virus"

Author: Versluys, Anne Birgitta; Boelens, Jaap Jan
Title: Morbidity and Mortality Associated With Respiratory Virus Infections in Allogeneic Hematopoietic Cell Transplant: Too Little Defense or Harmful Immunity?
  • Cord-id: x238hq9b
  • Document date: 2018_11_21
  • ID: x238hq9b
    Snippet: The impact on morbidity and mortality of Community Acquired Respiratory Virus (CARV) infections in patients undergoing Allogeneic Hematopoietic Cell Transplant (HCT) is widely studied. Here we give an overview of the current literature on the incidence and chance of progression to severe disease in this highly immune compromised population. We discuss the issue whether it is predominantly direct viral damage that causes clinical deterioration, or that it is in fact the allogeneic immuneresponse
    Document: The impact on morbidity and mortality of Community Acquired Respiratory Virus (CARV) infections in patients undergoing Allogeneic Hematopoietic Cell Transplant (HCT) is widely studied. Here we give an overview of the current literature on the incidence and chance of progression to severe disease in this highly immune compromised population. We discuss the issue whether it is predominantly direct viral damage that causes clinical deterioration, or that it is in fact the allogeneic immuneresponse to the virus that is most important. This is an important question as it will guide therapeutic decision making. It asks for further collaborative studies focusing on sensitive surveillance with PCR techniques and relating clinical data with parameters of immune reconstitution.

    Search related documents:
    Co phrase search for related documents
    • long persistence and lung disease: 1, 2
    • long term outcome and lung disease: 1, 2, 3
    • long term pulmonary function and lung disease: 1
    • longitudinal study and low immunity: 1
    • longitudinal study and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • low lymphocyte count and lrti develop: 1
    • low lymphocyte count and lrti progression: 1
    • low respiratory lrti tract infections and lrti tract infections: 1, 2, 3
    • low respiratory tract disease and lung disease: 1